Oaktree Acquisition Corp. III Life Sciences (OACC)
| Market Cap | 255.80M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | 2.66M |
| Shares Out | 24.58M |
| EPS (ttm) | n/a |
| PE Ratio | 96.64 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 105 |
| Open | 10.47 |
| Previous Close | 10.40 |
| Day's Range | 10.47 - 10.47 |
| 52-Week Range | 9.95 - 10.85 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About OACC
Oaktree Acquisition Corp. III Life Sciences focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is headquartered in Los Angeles, California. [Read more]
News
Oaktree Acquisition Corp. III Life Sciences Announces Pricing of $175 Million Initial Public Offering
Oaktree Acquisition Corp. III Life Sciences, a special purpose acquisition company formed for the purpose of entering into a combination with one or more businesses or entities...
SPAC Oaktree Acquisition III Life Sciences files for a $175 million IPO, formed by Oaktree Capital Management
Oaktree Acquisition III Life Sciences, a blank check company formed by Oaktree Capital targeting healthcare businesses, filed on Friday with the SEC to raise up to $175 million in an initial public of...
Oaktree Acquisition Corp. III Life Sciences IPO Registration Document (S-1)
Oaktree Acquisition Corp. III Life Sciences has filed to go public with an IPO on the NASDAQ.